Release Date: 15/11/22 15:35 Summary: Breaker completes Manna divestment Price Sensitive: Yes Download Document 149.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%